Duchenne Muscular Dystrophy Video Assessment Registry
NCT05712447 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2026-03-10
Summary
ARISE is a prospective and longitudinal clinical study of individuals with Duchenne Muscular Dystrophy (DMD) aimed at creating a database of functional motor abilities in this population to support validation efforts of the Duchenne Video Assessment (DVA).
Conditions
Sponsors & Collaborators
-
United States Department of Defense
collaborator FED -
The Emmes Company, LLC
lead INDUSTRY
Principal Investigators
-
Marielle Contesse, PhD · Emmes Endpoint Solutions
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2026-01-11
- Completion
- 2026-01-11
Countries
- United States
Study Locations
More Related Trials
-
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
NCT01753804 ·Status: TERMINATED
-
Research of Biomarkers in Duchenne Muscular Dystrophy Patients
NCT01380964 ·Status: COMPLETED
-
Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study
NCT02780492 ·Status: COMPLETED
-
Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients
NCT01396239 ·Status: COMPLETED ·Phase: PHASE2
-
Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography
NCT03490214 ·Status: COMPLETED ·Phase: NA
-
A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy
NCT03760029 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy
NCT02286947 ·Status: COMPLETED ·Phase: PHASE2
-
Decoding Central Defects in Dystrophinopathies From Diagnostic to Remediation
NCT07125898 ·Status: NOT_YET_RECRUITING
-
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
NCT02420379 ·Status: COMPLETED ·Phase: PHASE2
-
Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD)
NCT05338099 ·Status: COMPLETED ·Phase: PHASE1
-
ALS Research Collaborative
NCT06885918 ·Status: RECRUITING
-
Long-Term Development of Muscular Dystrophy Outcome Assessments
NCT05989620 ·Status: RECRUITING
-
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
NCT01540409 ·Status: COMPLETED ·Phase: PHASE2
-
Muscle Tissue Bank for Muscular Dystrophy
NCT01950897 ·Status: COMPLETED
-
Establishment of a Tissue Bank (Blood, CSF) for the Understanding of Motor Neuron Disease (MND)
NCT01950910 ·Status: TERMINATED
-
A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice
NCT04475926 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)
NCT06817382 ·Status: RECRUITING ·Phase: PHASE1
-
Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)
NCT03867435 ·Status: TERMINATED
-
Study of Genotype and Phenotype Characterization in Duchenne Muscular Dystrophy With Small Mutations
NCT05833633 ·Status: UNKNOWN
-
Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients
NCT00844597 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of ALS Reversals 2: Genetic Analyses
NCT03464903 ·Status: COMPLETED
-
Limb Girdle Muscular Dystrophy (LGMD) Natural History
NCT01783509 ·Status: COMPLETED
-
Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment
NCT04004065 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy
NCT02195999 ·Status: COMPLETED
-
Natural History Study of Patients With Limb-Girdle Muscular Dystrophy 2I
NCT03842878 ·Status: COMPLETED